Compare DERM & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | ONL |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 165.4M |
| IPO Year | 2021 | 2021 |
| Metric | DERM | ONL |
|---|---|---|
| Price | $7.45 | $2.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $12.67 | $3.00 |
| AVG Volume (30 Days) | 209.9K | ★ 310.5K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | $61,858,000.00 | ★ $147,647,000.00 |
| Revenue This Year | $39.72 | $4.10 |
| Revenue Next Year | $63.24 | $3.10 |
| P/E Ratio | ★ N/A | $15.21 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $1.92 |
| 52 Week High | $9.56 | $3.05 |
| Indicator | DERM | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 61.47 | 57.58 |
| Support Level | $7.39 | $2.81 |
| Resistance Level | $8.29 | $3.00 |
| Average True Range (ATR) | 0.44 | 0.09 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 68.27 | 84.09 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.